An unusual cause of progressive heart failure

Lancet

Volumn 357, Issue 9267, 2001, Pages 1498-

  Sinha, M K ^a   Lachmann, H J ^c   Kuriakose, B ^a   Abdulla, A K ^b   Aggarwal, R K ^a  

^a Department of Cardiology ^*  (United Kingdom)

^b BASILDON HOSPITAL   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; PREALBUMIN;

ADULT; AMYLOIDOSIS; ARTICLE; AUTONOMIC NEUROPATHY; BONE MARROW BIOPSY; CARDIOMYOPATHY; CHEMOTHERAPY; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; GENE MUTATION; HEART AMYLOIDOSIS; HEART DISEASE; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; MALE; PALLIATIVE THERAPY; PLASMA CELL; PLASMA CELL DYSCRASIA; PRIORITY JOURNAL; RECTUM BIOPSY; REMISSION; SURVIVAL RATE; SYMPTOM; TREATMENT OUTCOME;

EID: 0035849274     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04648-1     Document Type: Article

References (5)

1. McCarthy RE, Kasper EK. A review of amyloidoses that infiltrate the heart. Clin Cardiol 1998; 21: 547-52.
2. Jacobson DR, Pastore RD, Yaghoubian R, et al. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med 1997; 336: 466-73.
3. Saba N, Sutton D, Ross H, et al. High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant. Bone Marrow Transplant 1999; 24: 853-55.
4. Dubrey SW, Burke MM, Khaghini A, Hawkins PN, Yacoub MH, Banner NR. Long term results of heart transplantation in patients with amyloid heart disease. Heart 2001; 85: 202-07.
5. Hall R, Hawkins PN. Cardiac transplantation for AL amyloidosis: a personal account. BMJ 1994; 309: 1135-37.